PC
CC icon

Promus Capital’s Chemours CC Stock Holding History

Promus Capital’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$507 Hold
32
– – ﹤0.01% 296
2025
Q2 		$366 Hold
32
– – ﹤0.01% 300
2025
Q1 		$433 Hold
32
– – ﹤0.01% 308
2024
Q4 		$541 Buy
+32
New +$623 ﹤0.01% 297

Other funds holding CC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $2.92B AUM 30.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Promus Capital's CC Position: Q3 2025 in Review

Promus Capital held its Chemours (CC) position steady in Q3 2025 at 32 shares worth $507. The position accounts for ﹤0.01% of the portfolio, ranked #296.

Promus Capital first reported a position in CC in Q4 2024 and has held it in 4 quarters since. The position peaked at $541 in Q4 2024. 428 funds tracked by Wall St. Rank hold CC as of Q3 2025.

  • Promus Capital held 32 shares of Chemours worth $507 as of Q3 2025.
  • Promus Capital left its Chemours share count unchanged in Q3 2025.
  • Chemours made up ﹤0.01% of Promus Capital's portfolio in Q3 2025, its #296 holding.
  • Promus Capital first reported a position in Chemours in Q4 2024 and has held it in 4 quarters since.
  • Promus Capital's Chemours position peaked at $541 in Q4 2024.
  • 428 funds tracked by Wall St. Rank held Chemours as of Q3 2025.

Based on Promus Capital's 13F filing for Q3 2025, filed 13 Nov 2025.